Shengbo Liu - Dissemin

All papers authored by Shengbo Liu

This paper was not found in any repository, but could be made available legally by the author.

2023 Peimeng You, Shengbo Liu

, Qiaxuan Li, Daipeng Xie, Lintong Yao, Chenguang Guo, Zefeng Guo, Ting Wang, Hongrui Qiu, Yangzhong Guo, Junyu Li, Haiyu Zhou

Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma

Upload

Bin Xu, Fanjun Zeng, Jialong Deng, Lintong Yao, Shengbo Liu

, Hengliang Hou, Yucheng Huang

, Hongyuan Zhu, Shaowei Wu

, Qiaxuan Li

, Weijie Zhan

, Hongrui Qiu, Huili Wang, Yundong Li

, Xianzhu Yang

and 3 other authors

A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy

Upload

This paper is made freely available by the publisher.

Ting Wang, Liyu Cai, Zefeng Guo, Peimeng You, Shengbo Liu

, Hongrui Qiu, Hao Li, Shaowei Wu, HaiYu Zhou

Comparison of efficacy and safety of neoadjuvant regimens for resectable esophageal squamous cell carcinoma: A meta-analysis.

Download from doi.org

Shengbo Liu

, Qiaxuan Li, Peimeng You, Hongrui Qiu, HaiYu Zhou

Computational recognition of lncRNA signature of tumor-infiltrating activated CD4+ memory T cells with potential implications in prognosis and immunotherapy of lung adenocarcinoma.

Download from doi.org

2021 Haiyu Zhou, Lili Lin, Tao Qin, Wei Ren, Yujie Tan, Qiong Yang, Huixin Xu, Xinxin Xie, Yongjian Chen, Shengbo Liu

, Xing Li, Zhihua Li, Hai Hu, Yunfang Yu, Herui Yao

Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study

Download from doi.org

2020 Hai-Yu Zhou, Shao-Peng Zheng, An-Lin Li, Quan-Long Gao, Qi-Yun Ou, Yong-Jian Chen, Shao-Tao Wu, Da-Gui Lin, Sheng-Bo Liu

, Lu-Yu Huang

, Fa-Sheng Li, Hong-Yuan Zhu, Gui-Bin Qiao, Michael Lanuti, He-Rui Yao

and 1 other authors

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)

Download from doi.org

2019 Yunfang Yu, Dongqiang Zeng, Qiyun Ou, Shengbo Liu

, Anlin Li, Yongjian Chen, Dagui Lin, Quanlong Gao, Haiyu Zhou, Wangjun Liao, Herui Yao

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer

Download from doi.org

Qun Luo, Shengbo Liu

, Liming Xie, Yongjie Yu, Limin Zhou, Yuzhen Feng, De Cai

Corrigendum: Resveratrol Ameliorates Glucocorticoid-Induced Bone Damage in a Zebrafish Model

Download from doi.org

Distributing this paper is prohibited by the publisher

Hui-Zhi Yang, Jiaojiao Zhang, Jie Zeng, Shengbo Liu

, Fei Zhou, Fang Zhang, Francesca Giampieri

, Danila Cianciosi, Tamara Y. Forbes-Hernandez, Johura Ansary, Emilio Gil, RongYi Chen, Maurizio Battino

Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle

Upload

Qun Luo, Shengbo Liu

, Liming Xie, Yongjie Yu, Limin Zhou, Yuzhen Feng, De Cai

Resveratrol Ameliorates Glucocorticoid-Induced Bone Damage in a Zebrafish Model

Download from doi.org

2018 Yunfang Yu, Ying Wang, Shengbo Liu

, Qiyun Ou, Tuping Fu, Dagui Lin, Quanlong Gao, Zhaoying Zhan, Herui Yao

Role of immune checkpoint inhibitor, tumor vaccine and cellular immunotherapy in advanced non-small-cell lung cancer.

Download from doi.org

Ying Wang, Yunfang Yu, Shengbo Liu

, Qiyun Ou, Herui Yao

Cyclin-dependent kinases 4 and 6 inhibitors in HR+/HER2- advanced breast cancer.

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Shengbo Liu